BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yu JK, Chen YD, Zheng S. An integrated approach to the detection of colorectal cancer utilizing proteomics and bioinformatics. World J Gastroenterol 2004; 10(21): 3127-3131 [PMID: 15457557 DOI: 10.3748/wjg.v10.i21.3127]
URL: https://www.wjgnet.com/1007-9327/full/v10/i21/3127.htm
Number Citing Articles
1
Jose L. Luque-Garcia, Thomas A. Neubert. Sample preparation for serum/plasma profiling and biomarker identification by mass spectrometryJournal of Chromatography A 2007; 1153(1-2): 259 doi: 10.1016/j.chroma.2006.11.054
2
Jens K. Habermann, Franz G. Bader, Christian Franke, Kaja Zimmermann, Timo Gemoll, Britta Fritzsche, Thomas Ried, Gert Auer, Hans-Peter Bruch, Uwe J. Roblick. From the genome to the proteome—biomarkers in colorectal cancerLangenbeck's Archives of Surgery 2007; 393(1): 93 doi: 10.1007/s00423-007-0230-1
3
Kenneth E. Hung, Daniel C. Chung. Colorectal Cancer Screening: Today and TomorrowSouthern Medical Journal 2006; 99(3): 240 doi: 10.1097/01.smj.0000203817.89741.29
4
Hong He, Gang Sun, Feiyun Ping, Yanqing Cong. A New and Preliminary Three-dimensional Perspective: Proteomes of Optimization between OSCC and OLKArtificial Cells, Blood Substitutes, and Biotechnology 2011; 39(1): 26 doi: 10.3109/10731199.2010.516258
5
Y.-W. LIN, H.-C. LAI, C.-Y. LIN, J.-Y. CHIOU, H.-A. SHUI, C.-C. CHANG, M.-H. YU, T.-Y. CHU. Plasma proteomic profiling for detecting and differentiating in situ and invasive carcinomas of the uterine cervixInternational Journal of Gynecological Cancer 2006; 16(3): 1216 doi: 10.1111/j.1525-1438.2006.00583.x
6
Keishi Yamashita, Masahiko Watanabe. Clinical significance of tumor markers and an emerging perspective on colorectal cancerCancer Science 2009; 100(2): 195 doi: 10.1111/j.1349-7006.2008.01022.x
7
Candidate biomarker verification: Critical examination of a serum protein pattern for human colorectal cancerPROTEOMICS – Clinical Applications 2012; 6(3-4): 182 doi: 10.1002/prca.201100095
8
Eric T Fung, Scot R Weinberger, Ed Gavin, Fujun Zhang. Bioinformatics approaches in clinical proteomicsExpert Review of Proteomics 2005; 2(6): 847 doi: 10.1586/14789450.2.6.847
9
Xiao-hui Zhai, Jie-kai Yu, Chen Lin, Li-dong Wang, Shu Zheng. Combining proteomics, serum biomarkers and bioinformatics to discriminate between esophageal squamous cell carcinoma and pre-cancerous lesionJournal of Zhejiang University SCIENCE B 2012; 13(12): 964 doi: 10.1631/jzus.B1200066
10
D G Ward, N Suggett, Y Cheng, W Wei, H Johnson, L J Billingham, T Ismail, M J O Wakelam, P J Johnson, A Martin. Identification of serum biomarkers for colon cancer by proteomic analysisBritish Journal of Cancer 2006; 94(12): 1898 doi: 10.1038/sj.bjc.6603188
11
Sabrina Hundt, Ulrike Haug, Hermann Brenner. Blood Markers for Early Detection of Colorectal Cancer: A Systematic ReviewCancer Epidemiology, Biomarkers & Prevention 2007; 16(10): 1935 doi: 10.1158/1055-9965.EPI-06-0994
12
F.M. Smith, J.V. Reynolds, N. Miller, R.B. Stephens, M.J. Kennedy. Pathological and molecular predictors of the response of rectal cancer to neoadjuvant radiochemotherapyEuropean Journal of Surgical Oncology (EJSO) 2006; 32(1): 55 doi: 10.1016/j.ejso.2005.09.010
13
Fraser M. Smith, William M. Gallagher, Edward Fox, Richard B. Stephens, Elton Rexhepaj, Emanuel F. Petricoin, Lance Liotta, M John Kennedy, John V. Reynolds. Combination of SELDI-TOF-MS and Data Mining Provides Early-stage Response Prediction for Rectal Tumors Undergoing Multimodal Neoadjuvant TherapyAnnals of Surgery 2007; 245(2): 259 doi: 10.1097/01.sla.0000245577.68151.bd
14
Judith Y M N Engwegen, Niven Mehra, John B A G Haanen, Johannes M G Bonfrer, Jan H M Schellens, Emile E Voest, Jos H Beijnen. Validation of SELDI-TOF MS serum protein profiles for renal cell carcinoma in new populationsLaboratory Investigation 2007; 87(2): 161 doi: 10.1038/labinvest.3700503
15
Y.-W. LIN, C.-Y. LIN, H.-C. LAI, J.-Y. CHIOU, C.-C. CHANG, M.-H. YU, T.-Y. CHU. Plasma proteomic pattern as biomarkers for ovarian cancerInternational Journal of Gynecological Cancer 2006; 16(S1): 139 doi: 10.1111/j.1525-1438.2006.00475.x
16
Fu-Ming Qiu, Jie-Kai Yu, Yi-Ding Chen, Qi-Feng Jin, Mei-Hua Sui, Jian Huang. Mining novel biomarkers for prognosis of gastric cancer with serum proteomicsJournal of Experimental & Clinical Cancer Research 2009; 28(1) doi: 10.1186/1756-9966-28-126
17
Hui Meng, Wenxue Hong, Jialin Song, Liqiang Wang. Feature Extraction and Analysis of Ovarian Cancer Proteomic Mass Spectra2008 2nd International Conference on Bioinformatics and Biomedical Engineering 2008; : 668 doi: 10.1109/ICBBE.2008.163
18
Nishu Dalal, Rekha Jalandra, Minakshi Sharma, Hridayesh Prakash, Govind K. Makharia, Pratima R. Solanki, Rajeev Singh, Anil Kumar. Omics technologies for improved diagnosis and treatment of colorectal cancer: Technical advancement and major perspectivesBiomedicine & Pharmacotherapy 2020; 131: 110648 doi: 10.1016/j.biopha.2020.110648
19
Marie-Christine W. Gast, Carla H. van Gils, Lodewijk F.A. Wessels, Nathan Harris, Johannes M.G. Bonfrer, Emiel J.Th. Rutgers, Jan H.M. Schellens, Jos H. Beijnen. Influence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS)Clinical Chemistry and Laboratory Medicine 2009; 47(6) doi: 10.1515/CCLM.2009.151
20
Eugenio Ragazzi, Salvatore Pucciarelli, Roberta Seraglia, Laura Molin, Marco Agostini, Mario Lise, Pietro Traldi, Donato Nitti. Multivariate analysis approach to the plasma protein profile of patients with advanced colorectal cancerJournal of Mass Spectrometry 2006; 41(12): 1546 doi: 10.1002/jms.1113
21
Jia‐Xiang Wang, Jie‐kai Yu, Li Wang, Qiu‐Liang Liu, Jiao Zhang, Shu Zheng. Application of serum protein fingerprint in diagnosis of papillary thyroid carcinomaPROTEOMICS 2006; 6(19): 5344 doi: 10.1002/pmic.200500833
22
Magda Bakun, Jakub Karczmarski, Jaroslaw Poznanski, Tymon Rubel, Malgorzata Rozga, Agata Malinowska, Dorota Sands, Ewa Hennig, Janusz Oledzki, Jerzy Ostrowski, Michal Dadlez. An integrated LC‐ESI‐MS platform for quantitation of serum peptide ladders. Application for colon carcinoma studyPROTEOMICS – Clinical Applications 2009; 3(8): 932 doi: 10.1002/prca.200800111
23
Michael T. Davis, Paul Auger, Chris Spahr, Scott D. Patterson. Cancer biomarker discovery via low molecular weight serum proteome profiling – Where is the tumor?PROTEOMICS – Clinical Applications 2007; 1(12): 1545 doi: 10.1002/prca.200700141
24
J. S. Yu, S. Ongarello, R. Fiedler, X. W. Chen, G. Toffolo, C. Cobelli, Z. Trajanoski. Ovarian cancer identification based on dimensionality reduction for high-throughput mass spectrometry dataBioinformatics 2005; 21(10): 2200 doi: 10.1093/bioinformatics/bti370
25
Ki Tae Suk. An "Omics" Based Survey of Human Colon Cancer (Proteomics)Intestinal Research 2011; 9(1): 66 doi: 10.5217/ir.2011.9.1.66
26
Edmond O'Riordan, Steven S Gross, Michael S Goligorsky. Technology Insight: renal proteomics—at the crossroads between promise and problemsNature Clinical Practice Nephrology 2006; 2(8): 445 doi: 10.1038/ncpneph0241
27
M. Ventura, A. Sanchez-Niubo, F. Ruiz, N. Agell, R. Ventura, C. Angulo, A. Domingo-Salvany, J. Segura, R. de la Torre. Qualitative evaluation of chromatographic data from quality control schemes using a support vector machineThe Analyst 2008; 133(1): 105 doi: 10.1039/B711653P
28
Judith Y.M.N. Engwegen, Marie-Christine W. Gast, Jan H.M. Schellens, Jos H. Beijnen. Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometryTrends in Pharmacological Sciences 2006; 27(5): 251 doi: 10.1016/j.tips.2006.03.003
29
Shahida Din, Anne Marie Lennon, Ian DR Arnott, Ted Hupp, Jack Satsangi. Technology Insight: the application of proteomics in gastrointestinal diseaseNature Clinical Practice Gastroenterology & Hepatology 2007; 4(7): 372 doi: 10.1038/ncpgasthep0872
30
Douglas G Ward, Stephen Nyangoma, Howard Joy, Emma Hamilton, Wenbin Wei, Chris Tselepis, Neil Steven, Michael JO Wakelam, Philip J Johnson, Tariq Ismail, Ashley Martin. Proteomic profiling of urine for the detection of colon cancerProteome Science 2008; 6(1) doi: 10.1186/1477-5956-6-19
31
Harold Tjalsma. Identification of biomarkers for colorectal cancer through proteomics-based approachesExpert Review of Proteomics 2010; 7(6): 879 doi: 10.1586/epr.10.81
32
Nikhil Pawa, Tan Arulampalam, John D. Norton. Screening for colorectal cancer: established and emerging modalitiesNature Reviews Gastroenterology & Hepatology 2011; 8(12): 711 doi: 10.1038/nrgastro.2011.205
33
Anouck Huijbers, Berit Velstra, Tim J. A. Dekker, Wilma E. Mesker, Yuri E. M. van der Burgt, Bart J. Mertens, André M. Deelder, Rob A. E. M. Tollenaar. Proteomic Serum Biomarkers and Their Potential Application in Cancer Screening ProgramsInternational Journal of Molecular Sciences 2010; 11(11): 4175 doi: 10.3390/ijms11114175
34
ME de Noo, RAEM Tollenaar, AM Deelder, LH Bouwman. Current status and prospects of clinical proteomics studies on detection of colorectal cancer: Hopes and fearsWorld Journal of Gastroenterology 2006; 12(41): 6594-6601 doi: 10.3748/wjg.v12.i41.6594
35
Anita R Skandarajah, Robert L Moritz, Joe J Tjandra, Richard J Simpson. Proteomic analysis of colorectal cancer: discovering novel biomarkersExpert Review of Proteomics 2005; 2(5): 681 doi: 10.1586/14789450.2.5.681
36
Arunava Sankar Nath, Aparajita Pal, Somnath Mukhopadhyay, Kartick Chandra Mondal. A survey on cancer prediction and detection with data analysisInnovations in Systems and Software Engineering 2020; 16(3-4): 231 doi: 10.1007/s11334-019-00350-6
37
Thomas Göbel, Sonja Vorderwülbecke, Katarzyna Hauck, Holger Fey, Dieter Häussinger, Andreas Erhardt. New multi protein patterns differentiate liver fibrosis stages and hepatocellular carcinoma in chronic hepatitis C serum samplesWorld Journal of Gastroenterology 2006; 12(47): 7604-7612 doi: 10.3748/wjg.v12.i47.7604
38
David F. Ransohoff, Christopher Martin, Wesley S. Wiggins, Ben A. Hitt, Temitope O. Keku, Joseph A. Galanko, Robert S. Sandler. Assessment of Serum Proteomics to Detect Large Colon AdenomasCancer Epidemiology, Biomarkers & Prevention 2008; 17(8): 2188 doi: 10.1158/1055-9965.EPI-07-2767
39
Judith Y.M.N. Engwegen, Annekatrien C.T.M. Depla, Marianne E. Smits, Annemieke Cats, Henriëtte Tuynman, Henk A. Van Heukelem, Pleun Snel, Wouter Meuleman, Lodewyk F. Wessels, Jan H.M. Schellens, Jos H. Beijnen. Detection of Colorectal Cancer by Serum and Tissue Protein Profiling: A Prospective Study in a Population at RiskBiomarker Insights 2008; 3: BMI.S790 doi: 10.4137/BMI.S790
40
Jennifer Colangelo, Michael Lawton, William Pennie. Surrogate Tissue Analysis2005; : 275 doi: 10.1201/9781420038095.ch17
41
Shao-Pai Wu, Ya-Wen Lin, Hung-Cheng Lai, Tang-Yuan Chu, Yu-Liang Kuo, Hang-Seng Liu. Seldi-tof MS Profiling of Plasma Proteins in Ovarian CancerTaiwanese Journal of Obstetrics and Gynecology 2006; 45(1): 26 doi: 10.1016/S1028-4559(09)60186-8
42
Grania Christyani, Matthew Carswell, Sisi Qin, Wootae Kim. An Overview of Advances in Rare Cancer Diagnosis and TreatmentInternational Journal of Molecular Sciences 2024; 25(2): 1201 doi: 10.3390/ijms25021201
43
N.A. Henderson, R.J.C. Steele. SELDI-TOF proteomic analysis and cancer detectionThe Surgeon 2005; 3(6): 383 doi: 10.1016/S1479-666X(05)80048-4
44
Bilal Alaiyan, Nadia Ilyayev, Alexander Stojadinovic, Mina Izadjoo, Marina Roistacher, Vera Pavlov, Victoria Tzivin, David Halle, Honguang Pan, Barry Trink, Ali O Gure, Aviram Nissan. Differential expression of colon cancer associated transcript1 (CCAT1) along the colonic adenoma-carcinoma sequenceBMC Cancer 2013; 13(1) doi: 10.1186/1471-2407-13-196
45
Erika Hissong, Meredith E. Pittman. Colorectal carcinoma screening: Established methods and emerging technologyCritical Reviews in Clinical Laboratory Sciences 2020; 57(1): 22 doi: 10.1080/10408363.2019.1670614
46
Carol R. Regueiro. AGA Future Trends Committee Report: Colorectal Cancer: A Qualitative Review of Emerging Screening and Diagnostic TechnologiesGastroenterology 2005; 129(3): 1083 doi: 10.1053/j.gastro.2005.06.012
47
Wenxue Hong, Hui Meng, Liqiang Wang, Jialin Song. Advanced Intelligent Computing Theories and Applications. With Aspects of Theoretical and Methodological IssuesLecture Notes in Computer Science 2007; 4681: 1231 doi: 10.1007/978-3-540-74171-8_125
48
Biomarker Signature Discovery from Mass Spectrometry DataIEEE/ACM Transactions on Computational Biology and Bioinformatics 2014; 11(4): 766 doi: 10.1109/TCBB.2014.2318718
49
Peter Findeisen, Michael Neumaier. Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspectiveClinical Chemistry and Laboratory Medicine 2009; 47(6) doi: 10.1515/CCLM.2009.159
50
Eline Berghmans, Kurt Boonen, Evelyne Maes, Inge Mertens, Patrick Pauwels, Geert Baggerman. Implementation of MALDI Mass Spectrometry Imaging in Cancer Proteomics Research: Applications and ChallengesJournal of Personalized Medicine 2020; 10(2): 54 doi: 10.3390/jpm10020054
51
Judith YMN Engwegen, Helgi H Helgason, Annemieke Cats, Nathan Harris, Johannes MG Bonfrer, Jan HM Schellens, Jos H Beijnen. Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometryWorld Journal of Gastroenterology 2006; 12(10): 1536-1544 doi: 10.3748/wjg.v12.i10.1536
52
Zhihao Xing, Chen Chu, Lei Chen, Xiangyin Kong. The use of Gene Ontology terms and KEGG pathways for analysis and prediction of oncogenesBiochimica et Biophysica Acta (BBA) - General Subjects 2016; 1860(11): 2725 doi: 10.1016/j.bbagen.2016.01.012
53
Shen Hu, Joseph A. Loo, David T. Wong. Human body fluid proteome analysisPROTEOMICS 2006; 6(23): 6326 doi: 10.1002/pmic.200600284
54
Hao Wang, Chenghua Luo, Shengtao Zhu, Honghong Fang, Qing Gao, Siqi Ge, Haixia Qu, Qingwei Ma, Hongwei Ren, Youxin Wang, Wei Wang. Serum peptidome profiling for the diagnosis of colorectal cancer: discovery and validation in two independent cohortsOncotarget 2017; 8(35): 59376 doi: 10.18632/oncotarget.19587
55
Mirre E. de Noo, Bart J.A. Mertens, Aliye Özalp, Marco R. Bladergroen, Martijn P.J. van der Werff, Cornelis J.H. van de Velde, Andre M. Deelder, Rob A.E.M. Tollenaar. Detection of colorectal cancer using MALDI-TOF serum protein profilingEuropean Journal of Cancer 2006; 42(8): 1068 doi: 10.1016/j.ejca.2005.12.023
56
Kwasi Antwi, Galen Hostetter, Michael J. Demeure, Benjamin A. Katchman, G. Anton Decker, Yvette Ruiz, Timothy D. Sielaff, Lawrence J. Koep, Douglas F. Lake. Analysis of the Plasma Peptidome from Pancreas Cancer Patients Connects a Peptide in Plasma to Overexpression of the Parent Protein in TumorsJournal of Proteome Research 2009; 8(10): 4722 doi: 10.1021/pr900414f
57
Nicholas P. Munro, David A. Cairns, Paul Clarke, Mark Rogers, Anthea J. Stanley, Jennifer H. Barrett, Patricia Harnden, Douglas Thompson, Ian Eardley, Rosamonde E. Banks, Margaret A. Knowles. Urinary biomarker profiling in transitional cell carcinomaInternational Journal of Cancer 2006; 119(11): 2642 doi: 10.1002/ijc.22238
58
XIAO-HUI ZHAI, JIE-KAI YU, FU-QUAN YANG, SHU ZHENG. Identification of a new protein biomarker for colorectal cancer diagnosisMolecular Medicine Reports 2012; 6(2): 444 doi: 10.3892/mmr.2012.923
59
Abedalrhman Alkhateeb, Ashraf Abou Tabl, Luis Rueda. Deep Learning for Biomedical Data Analysis2021; : 255 doi: 10.1007/978-3-030-71676-9_11